LIVN LivaNova PLC

  1. Stocks
  2. Healthcare
  3. NASDAQ: LIVN

Price (delayed)

$77.16

Market cap

$4.25B

P/E Ratio

22.43

Dividend/share

N/A

EPS

$3.44

Enterprise value

$4.08B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 92

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through medical technologies, ...

Highlights
LivaNova's EPS has surged by 189% YoY and by 76% QoQ
The net income has soared by 189% YoY and by 76% from the previous quarter
LIVN's debt is down by 28% year-on-year but it is up by 2.6% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.livanova.com
Peers: OFIX

Key stats

What are the main financial stats of LIVN

LIVN stock price

How has the LivaNova stock price performed over time
Intraday
-1.69%
1 week
-1.72%
1 month
-2.01%
1 year
42.99%
YTD
25.4%
QTD
-6.17%

Financial performance

How have LivaNova's revenue and profit performed over time
Revenue
$1.47B
Gross profit
$1B
Operating income
$187.55M
Net income
$188.55M
Gross margin
68.1%
Net margin
12.8%
The net income has soared by 189% YoY and by 76% from the previous quarter
LIVN's net margin has soared by 180% year-on-year and by 71% since the previous quarter
The gross profit has grown by 13% YoY and by 3.6% from the previous quarter
LivaNova's revenue has increased by 12% YoY and by 2.7% from the previous quarter

Price vs fundamentals

How does LIVN's price correlate with its fundamentals

Growth

What is LivaNova's growth rate over time

Valuation

What is LivaNova stock price valuation
LIVN P/E details
P/E
22.43
P/B
3.2
P/S
2.88
EV/EBIT
28.37
EV/EBITDA
19.66
EV/Sales
2.77
LivaNova's EPS has surged by 189% YoY and by 76% QoQ
The price to book (P/B) is 30% higher than the 5-year quarterly average of 2.5 and 12% higher than the last 4 quarters average of 2.9
The equity rose by 18% year-on-year and by 9% since the previous quarter
The price to sales (P/S) is 17% higher than the last 4 quarters average of 2.5 and 9% higher than the 5-year quarterly average of 2.7
LivaNova's revenue has increased by 12% YoY and by 2.7% from the previous quarter

Efficiency

How efficient is LivaNova business performance
The company's return on assets has surged by 187% YoY and by 74% QoQ
The return on equity has surged by 187% year-on-year and by 69% since the previous quarter
The ROIC has contracted by 22% from the previous quarter
LivaNova's return on sales has decreased by 16% QoQ

Dividends

What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LIVN.

Financial health

How did LivaNova financials performed over time
The company's total assets is 101% higher than its total liabilities
The current ratio has grown by 12% year-on-year and by 9% since the previous quarter
LivaNova's quick ratio has increased by 8% YoY and by 5% QoQ
LIVN's debt is 74% smaller than its equity
LIVN's debt to equity is down by 38% year-on-year and by 7% since the previous quarter
LIVN's debt is down by 28% year-on-year but it is up by 2.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.